Vakratund Pharmaceuticals Private Limited
About Vakratund Pharmaceuticals Private Limited
Data last updated:
Vakratund Pharmaceuticals Private Limited is a private limited company based in Udaipur, Rajasthan, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 11 October 2002 and has been in existence for over 24 years.
The company is registered with the Registrar of Companies (ROC), Jaipur, under CIN U24232RJ2002PTC017864. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹19 Lakh. It is led by directors Deependra Singh Mewara and Shobha Mewara.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Gudli Industrial Area Plot No.G – 1 216 – 221, Udaipur, Rajasthan, India.
As per the financials filed for FY 2025, the company reported a revenue of ₹17,000. For the same year it recorded a net loss of ₹2.75 Lakh and EBITDA of ₹10,407 (EBITDA margin 61.2%).
As per MCA filings, the company has satisfied charges of ₹1.65 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Vakratund Pharmaceuticals Private Limited's registered office is in Udaipur, Rajasthan. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressGudli Industrial Area Plot No.G – 1 216 – 221, Udaipur, Rajasthan, India
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Vakratund Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Vakratund Pharmaceuticals Private Limited
FY 2025 filings availableVakratund Pharmaceuticals Private Limited reported revenue of ₹17,000 for FY 2025.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹10,407 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹2.75 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 61.2% | ||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Vakratund Pharmaceuticals Private Limited, buy the company report.
Board of directors of Vakratund Pharmaceuticals Private Limited
Vakratund Pharmaceuticals has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Deependra Singh Mewara | Director | 08 Mar 2021 | 5 Years 8 Months | Current |
| Shobha Mewara Also directs: Hotel Abhirang Pvt. Ltd | Director | 01 Dec 2010 | 15 Years 11 Months | Current |
Peer comparison
Vakratund Pharmaceuticals Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Gallant Pharmaceuticals Private Limited. | ₹18,000 (FY 2017) | Kaithal, Haryana, India | ||||
| Omega Century Institute of Oncology Private Limited | ₹18,000 (FY 2025) | -99.0% | Hyderabad, Telangana, India | |||
| Medpro Marketing Private Limited | ₹17,522 (FY 2023) | 8.0% | Chennai, Tamil Nadu, India | |||
| Citadel Aurobindo Biotech Limited | ₹17,164 (FY 2019) | -44.0% | Chennai, Tamil Nadu, India | |||
| Stepup Arogyam India Private Limited | ₹17,080 (FY 2025) | -79.0% | Surat, Gujarat, India | |||
| Vakratund Pharmaceuticals Private Limitedthis company | ₹17,000 (FY 2025) | -₹2.75 Lakh | Udaipur, Rajasthan, India | |||
| Infinity Learning Private Limited | ₹16,988 (FY 2024) | -92.0% | Bangalore, Karnataka, India | |||
| Shreesatguru Pharmaceuticals Private Limited | ₹16,924 (FY 2025) | Allahabad, Uttar Pradesh, India | ||||
| RG Drugs and Pharma Private Limited | ₹16,900 (FY 2023) | New Delhi, Delhi, India | ||||
| Harivista Pharmaceuticals Private Limited | ₹16,648 (FY 2023) | Mysore, Karnataka, India | ||||
| Shrivaidyanath Pharmaceuticals Private Limited | ₹16,550 (FY 2025) | 5.0% | Alwar, Rajasthan, India |
To see the full peer comparison of Vakratund Pharmaceuticals Private Limited, buy the company report.
Auditor
Vakratund Pharmaceuticals Private Limited is audited by GARG & ASSOCIATES for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| GARG & ASSOCIATES | FY 2019 | 000185C |
Shareholding
The shareholding of Vakratund Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Vakratund Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 19 Jun 2006 | 10008870 | The Udaipur Urban Co-Operative Bank Limited | ₹47 Lakh | Satisfied | |
| 08 May 2004 | 90071250 | The Udaipur Urban Co-Operative Bank Limited | ₹20 Lakh | Satisfied | |
| 03 Oct 2003 | 80064117 | The Udaipur Urban Co-Operative Bank Ltd. | ₹78 Lakh | Satisfied | |
| 03 Oct 2003 | 90071097 | The Udaipur Urban Co-Operative Bank Ltd | ₹20 Lakh | Satisfied |
To see the full charge records of Vakratund Pharmaceuticals Private Limited, buy the company report.
Total charge records: 4 View all charges
Legal cases
No court or tribunal cases involving Vakratund Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Vakratund Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Vakratund Pharmaceuticals has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Vakratund Pharmaceuticals Private Limited, buy the company report.
Recent activity
Vakratund Pharmaceuticals Private Limited has 5 board changes on record since 2010: 2 appointments and 3 cessations. The latest: Deependra Singh Mewara was appointed as Director on 08 Mar 2021.
6 earlier events are in the company report.
Frequently asked questions
Vakratund Pharmaceuticals is an active private limited company based in Udaipur, Rajasthan, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 11 October 2002 (24+ years old) and is registered under CIN U24232RJ2002PTC017864.
Vakratund Pharmaceuticals has 2 current directors:
- Deependra Singh Mewara - Director
- Shobha Mewara - Director
The latest financial statements of Vakratund Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
No. Vakratund Pharmaceuticals has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Vakratund Pharmaceuticals is U24232RJ2002PTC017864. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Vakratund Pharmaceuticals was incorporated on 11 October 2002, making it 24+ years old. It is registered with the Registrar of Companies, Jaipur.
The peers of Vakratund Pharmaceuticals by revenue are Gallant Pharmaceuticals Private Limited, Omega Century Institute of Oncology Private Limited, Medpro Marketing Private Limited, Citadel Aurobindo Biotech Limited, Stepup Arogyam India Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals).
Deependra Singh Mewara was appointed as Director on 08 Mar 2021. Prem Chand Mewara ceased to be Director on 11 Feb 2021. Deependra Singh Mewara ceased to be Director on 06 Dec 2010. Vakratund Pharmaceuticals has 5 board changes on record in total.
The registered office of Vakratund Pharmaceuticals is at Gudli Industrial Area Plot No.G – 1 216 – 221, Udaipur, Rajasthan, India.
Vakratund Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Vakratund Pharmaceuticals has no open charges and satisfied charges of ₹1.65 Cr as per latest MCA filings.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
